billS3939Event Thursday, February 26, 2026Analyzed

Chesapeake WATERS Act

Neutral

Summary

The Chesapeake WATERS Act is an early-stage procedural authorization bill that reauthorizes NOAA's Chesapeake Bay Office without specifying funding levels. It has no near-term market impact on any public company.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.Chesapeake WATERS Act is purely procedural with zero authorized funding
  • 2.No market impact on any public company in the near term
  • 3.Bill is in early legislative stages with long path to enactment

Market Implications

No market implications. The bill has no funding authorization and does not affect the revenue, costs, or competitive position of any publicly traded company. Investors should not allocate attention to this legislation for trading decisions.

Full Analysis

  1. What happened and its current status: The Chesapeake WATERS Act (S.3939) was introduced in the Senate on February 26, 2026, by Sen. Warner (D-VA) and cosponsored by three other senators. It was read twice and referred to the Committee on Commerce, Science, and Transportation. The bill is in early legislative stages with no further action since introduction.

  2. The money trail: The bill is a reauthorization bill that amends the National Oceanic and Atmospheric Administration Authorization Act of 1992. It does not authorize any specific dollar amount for funding. Authorization bills set policy and spending ceilings, but actual funding requires a separate appropriations bill. No direct or indirect funding stream to any private company is established.

  3. Structural winners and losers: No public company is structurally affected by this bill. The bill refocuses NOAA's Chesapeake Bay Office on education, integrated ecosystem assessments, coastal hazards, and climate change research. It does not create procurement mandates, tax incentives, or regulatory changes that would alter revenue or costs for any publicly traded entity.

  4. Market context: There is no market data provided for any company linked to this legislation. The bill's administrative nature and lack of funding authorization mean it does not move any sector measurably.

  5. Timeline: The bill requires committee hearings, a committee vote, passage by the full Senate, passage by the House (companion bill HR6893 is in subcommittee), and presidential signature. Given its early referral status and no scheduled hearings, passage in the current Congress is uncertain.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →